ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,307.58
-0.04%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Addex Therapeutics Ltd (ADXN)

  7. Addex Therapeutics Ltd (ADXN) News

Addex Therapeutics (ADXN)

Addex Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADXN
DateTimeSourceHeadlineSymbolCompany
06/06/202412:29IH Market NewsUS Index Futures Mixed; Oil Prices RiseNASDAQ:ADXNAddex Therapeutics Ltd
06/06/202411:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
06/06/202406:00GlobeNewswire Inc.Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
05/06/202411:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
05/06/202406:00GlobeNewswire Inc.Addex Convenes Annual General Meeting 2024NASDAQ:ADXNAddex Therapeutics Ltd
31/05/202406:00GlobeNewswire Inc.Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024NASDAQ:ADXNAddex Therapeutics Ltd
08/05/202406:00GlobeNewswire Inc.Addex to Present at Bio€quity Europe 2024NASDAQ:ADXNAddex Therapeutics Ltd
29/04/202406:00GlobeNewswire Inc.Addex Provides Update on ADX71149 Phase 2 Epilepsy StudyNASDAQ:ADXNAddex Therapeutics Ltd
19/04/202406:00GlobeNewswire Inc.Addex to Present at the Swiss Biotech Day 2024NASDAQ:ADXNAddex Therapeutics Ltd
18/04/202406:00GlobeNewswire Inc.Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
11/04/202406:00GlobeNewswire Inc.Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024NASDAQ:ADXNAddex Therapeutics Ltd
03/04/202406:00GlobeNewswire Inc.Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological DisordersNASDAQ:ADXNAddex Therapeutics Ltd
14/03/202406:00GlobeNewswire Inc.Addex to Present at the Bio-Europe Spring 2024 ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
31/01/202406:00GlobeNewswire Inc.Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.NASDAQ:ADXNAddex Therapeutics Ltd
30/01/202422:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ADXNAddex Therapeutics Ltd
30/01/202421:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
09/01/202406:00GlobeNewswire Inc.Addex to Present at the Swiss Equities Baader ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
05/01/202406:30GlobeNewswire Inc.Addex to Present at Biotech Showcase™ 2024NASDAQ:ADXNAddex Therapeutics Ltd
21/12/202311:00Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
20/12/202311:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
20/12/202306:00GlobeNewswire Inc.Addex Shareholders Approve All Resolutions at Extraordinary General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
14/12/202311:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
14/12/202306:00GlobeNewswire Inc.Addex Creates Treasury SharesNASDAQ:ADXNAddex Therapeutics Ltd
08/12/202319:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
30/11/202321:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADXNAddex Therapeutics Ltd
30/11/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADXNAddex Therapeutics Ltd
29/11/202321:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
29/11/202311:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ADXNAddex Therapeutics Ltd
29/11/202311:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
29/11/202306:00GlobeNewswire Inc.Addex Reports Q3 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:ADXN

Your Recent History

LSE
POS
Plexus
LSE
GKP
Gulf Keystone Petroleum
LSE
SBTX
Skinbiotherapeutics
LSE
LLOY
Lloyds Banking
LSE
GDR
Genedrive
LSE
SOLG
Solgold
LSE
AGL
Angle
LSE
GCM
Gcm Resources
LSE
BIRD
Blackbird
LSE
GOLD
LSE
TW.
Taylor Wimpey
LSE
VAST
Vast Resources
LSE
PANR
Pantheon Resources
LSE
RKH
Rockhopper Exploration
LSE
SAR
Sareum
LSE
SRT
Srt Marine Systems
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved